Pharma Stocks Rally on US Biosecure Act Boost

Pharma stocks rose on December 19 after the US Senate passed the Biosecure Act, curbing funding to certain Chinese biotech firms. The move lifted the Nifty Pharma index up to 0.65 percent, with investors betting Indian CDMOs like

Divi’s Labs could benefit as the US seeks alternatives to China in biotech supply chains.